Pegasus makes three new appointments

Pegasus has filled three new senior positions within its growing pharma and life sciences division.

James Osborn has joined Pegasus in the role of associate director, having spent a decade working in various health communications positions. He previously worked at 90TEN Healthcare, where he managed communications for the launch of the world's first biosimilar monoclonal antibody.

Meanwhile, two existing team members have been promoted to the post of account director. Yasmin Ghariani, who joined Pegasus in February 2013 from Spink, has been handed the new role after nine years in the communications industry, showing exceptional client management skills.

Megan Hollingdale, also formerly of Spink, has received her promotion after two years at Pegasus and with four years' previous experience in the sector.

Jo Spadaccino, director and head of pharma and life sciences at Pegasus, said: "Our success is dependent on our people and their passion to deliver against our mission to inspire healthy decisions. We warmly welcome James to the team, and congratulate Yasmin and Megan on their well-deserved promotions."

The agency was recently awarded the consultancy of the year prize at the 2016 Communique Awards, and is preparing to merge with Ashfield Healthcare Communications following its acquisition by UDG Healthcare.